Biological response under treatment and prognostic value of protein induced by vitamin K absence or antagonist-II in a French cohort of patients with hepatocellular carcinoma-Reference-Cited by-同舟云学术

Biological response under treatment and prognostic value of protein induced by vitamin K absence or antagonist-II in a French cohort of patients with hepatocellular carcinoma

Published:2019-12-31 Issue:10 Volume:32 Page:1364-1372
ISSN:0954-691X
Container-title:European Journal of Gastroenterology & Hepatology
language:en
Short-container-title:

Author:

Payancé Audrey,Dioguardi Burgio Marco,Peoc’h Katell,Achahboun Mohamed,Albuquerque Miguel,Devictor Julie,Chor Hélène,Manceau Hana,Soubrane Olivier,Durand François,Castera Laurent,Bouattour Mohamed,Paradis Valérie

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference31 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.;Ferlay;Int J Cancer,2015

2. Surveillance for hepatocellular carcinoma in patients with cirrhosis improves outcome.;Stravitz;Am J Med,2008

3. EASL clinical practice guidelines: management of hepatocellular carcinoma.;Galle;J Hepatol,2018

4. Evaluation of antiangiogenic efficacy in advanced hepatocellular carcinoma: biomarkers and functional imaging.;Bouattour;World J Hepatol,2015

5. Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey.;Ikai;Cancer,2004

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic significance of postoperative serological incomplete conversion of AFP and PIVKA-II after hepatic resection for hepatocellular carcinoma: a multicenter analysis of 1755 patients;The Oncologist;2024-06-22

2. Association of Serum Levels and Immunohistochemical Labelling of Des-Gamma-Carboxy-Prothrombin in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma;Diagnostics;2024-04-25

3. Prognostic value of des‑γ‑carboxyprothrombin in patients with AFP‑negative HCC treated with TACE;Oncology Letters;2022-12-29

4. Clinical value of serum AFP and PIVKA‐II for diagnosis, treatment and prognosis of hepatocellular carcinoma;Journal of Clinical Laboratory Analysis;2022-12-29

5. Prothrombin induced by vitamin K absence or antagonist-II (PIVKA-II) predicts complete responses of transarterial chemoembolization for hepatocellular carcinoma;Journal of the Formosan Medical Association;2022-08